Abstract
Pioneering protein engineering work by Kobilka et al. utilized chimeric constructs between α- and β-adrenergic receptors, and mutant receptors with partial deletions to identify domains involved in G-protein coupling and specific ligand binding (1). Since then, this method has been employed extensively in structure-function studies of many different G-protein-coupled, seven transmembrane domain (7TMD) receptors (reviewed in ref. 2). Recent application of the technique to the analysis of the interleukin-8 chemokine receptors, IL-8RA and IL8-RB, has served to indicate that the receptor-ligand interaction can be highly complex, with multiple domains contributing to ligand binding and, independently, to signal transduction (3). On the other hand, study of the Duffy antigen receptor for chemokines (DARC) suggests that chemokine binding by this promiscuous molecule is primarily localized to the first extracellular (N-terminal) domain (4,5). Comparison of amino acid sequence and function between coreceptor homologs of different species can highlight conserved regions likely to be involved in ligand binding and signal transduction (5). A strategy of specifically modifying individual or small groups of charged residues has also been employed to assess structure and function of 7TMD receptors. Such site-directed mutagenesis of the type A IL-8 receptor has been used to demonstrate that certain residues in the N-terminal domain and third extracellular loop are critical for ligand binding (6,7).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kobilka, B. K., Kobilka, T. S., Daniel, K., Regan, J. W., Caron, M. G., and Lefkowitz, R. J. (1988) Chimeric a2- ,β2- adrenergic receptors: Delineation of domains involved in effector coupling and ligand binding specificity. Science 240, 1310–1316.
Schwartz, T. W. (1994) Locating ligand-binding sites in 7TM receptors by protein engineering. Curr. Op. Biotechnol.5, 434–444.
Ahuja, S. K., Lee, J. C., and Murphy, P. M. (1996) CXC chemokines bind to a unique set of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct. J. Biol. Chem. 271, 225–232.
Lu, Z. H., Wang, Z. X., Horuk, R., Hesselgesser, J., Lou, Y. C., Hadley, T. J., and Peiper, S. C. (1995) The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino-terminal domain. J. Biol. Chem. 270, 26,239–26,245.
Horuk, R., Martin, A., Hesselgesser, J., Hadley, T., Lu, Z. H., Wang, Z. X., and Peiper, S. C. (1996) The Duffy antigen receptor for chemokines: structural analysis and expression in the brain. J. Leukoc. Biol. 59, 29–38.
Hebert, C. A., Vitangcol, R. V., and Baker, J. B. (1991) Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. J. Biol. Chem. 266,18,989–18,994.
Hebert, C. A., Chuntharapai, A., Smith, M., Colby, T., Kim, J., and Horuk, R. (1993) Partial functional mapping of the human interleukin-8 type A receptor. Identification of a major ligand binding domain. J. Biol. Chem. 268, 18,549–18,553.
Liao, F., Alkhatib, G., Peden, K. W., Sharma, G., Berger, E. A., and Farber, J. M. (1997) STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J. Exp. Med. 185, 2015–2023.
Rucker, J., Edinger, A. L., Sharron, M., Samson, M., Lee, B., Berson, J. F., et al. (1997) Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J. Virol. 71, 8999–9007.
Farzan, M., Choe, H., Martin, K., Marcon, L., Hofmann, W., Karlsson, G., et al. (1997) Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J. Exp. Med. 186, 405–411.
Choe, H., Farzan, M., Konkel, M., Martin, K., Sun, Y., Marcon, L., et al. (1998) The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1. J. Virol. 72, 6113–6118.
Bjorndal, A., Deng, H., Jansson, M., Fiore, J. R., Colognesi, C., Karlsson, A., et al. (1997) Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J. Virol. 71, 7478–7487.
Edinger, A. L., Amedee, A., Miller, K., Doranz, B. J., Endres, M., Sharron, M., et al. (1997) Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc. Natl. Acad. Sci. USA 94, 4005–4010.
Asjo, B., Morfeldt Manson, L., Albert, J., Biberfeld, G., Karlsson, A., Lidman, K., et al. (1986) Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 2, 660–662.
Connor, R. I., Mohri, H., Cao, Y., and Ho, D. D. (1993) Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J. Virol. 67, 1772–1777.
Roos, M. T., Lange, J. M., de Goede, R. E., Coutinho, R. A., Schellekens, P. T., et al. (1992) Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. J. Infect. Dis. 165, 427–432.
Schuitemaker, H., Koot, M., Kootstra, N. A., Dercksen, M. W., de Goede, R. E., van Stoenwij, K., et al. (1992) Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66, 1354–1360.
Zhu, T., Mo, H., Wang, N., Nam, D. S., Cao, Y., Koup, R. A., and Ho, D. D. (1993) Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261,1179–1181.
Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S., and Landau, N. R. (1997) Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185,621–628.
Scarlatti, G., Tresoldi, E., Bjorndal, A., Frederiksson, R., Colognesi, C., Deng, H. K., et al. (1997) In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nature Med. 3, 1259–1265.
Tersmette, M., de Goede, R. E., Al, B. J., Winkel, I. N., Gruters, R. A., Cuypers, H., et al. (1988) Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium- inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62, 2026–2032.
Tersmette, M., Gruters, R. A., de Wolf, F., de Goede, R. E., Lange, J. M., Schellekens, P. T., et al. (1989) Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J. Virol. 63, 2118–2125.
Tersmette, M., Lange, J. M., de Goede, R. E., de Wolf, F., Eeftink Schattenkerk, J. K., Schellekens, P. T., et al. (1989) Association between biological properties of human immuno-deficiency virus variants and risk for AIDS and AIDS mortality. Lancet1, 983–985.
Spijkerman, I. J., Koot, M., Prins, M., Keet, I. P., van den Hoek, A. J., Miedema, F., and Coutinho, R. A. (1995) Lower prevalence and incidence of HIV-1 syncytium-inducing pheno-type among injecting drug users compared with homosexual men. AIDS 9, 1085–1092.
Fiore, J. R., Bjorndal, A., Peipke, K. A., Di Stefano, M., Angarano, G., Pastore, G., et al. (1994) The biological phenotype of HIV-1 is usually retained during and after sexual transmission. Virology 204, 297–303.
Valentin, A., Albert, J., Fenyo, E. M., and Asjo, B. (1994) Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates. J. Virol. 68, 6684–6689.
Simmons, G., Wilkinson, D., Reeves, J. D., Dittmar, M. T., Beddows, S., Weber, J., et al. (1996) Primary, syncytium inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 70, 8355–8360.
He, J., Chen, Y., Farzan, M., Choe, H., Ohagen, A., Gartner, S., et al. (1997) CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385, 645–649.
de Wolf, F., Hogervorst, E., Goudsmit, J., Fenyo, E. M., Rubsamen Waigmann, H., Holmes, H., et al. (1994) Syncytium-inducing and non-syncytium-inducing capacity of human immuno-deficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization. AIDS Res. Hum. Retroviruses 10,1387–1400.
Boyd, M. T., Simpson, G. R., Cann, A. J., Johnson, M. A., and Weiss, R. A. (1993) A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism. J. Virol. 67, 3649–3652.
Fouchier, R. A., Groenink, M., Kootstra, N. A., Tersmette, M., Huisman, H. G., et al. (1992) Phenotype-associated sequence variation in the third variable domain of the human immuno-deficiency virus type 1 gp120 molecule. J. Virol. 66, 3183–3187.
Groenink, M., Fouchier, R. A., Broersen, S., Baker, C. H., Koot, M., Miedema, F., et al. (1993) Relation ofphenotype evolution of HIV-1 to envelope V2 configuration. Science 260,1513–1516.
Sabri, F., Chiodi, F., and Fenyo, E.-M. (1996) Lack of correlation between V3 amino acid sequence and syncytium-inducing capacity of some HIV type 1 isolates. AIDS Res. Hum. Retroviruses 12, 855–858.
Jansson, M., Popovic, M., Karlsson, A., Cocchi, F., Rossi, P., et al. (1996) Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 iso-lates. Proc. Natl. Acad. Sci. USA. 93,15382–15387.
Broder, C. C. and Collman, R. G. (1997) Chemokine receptors and HIV. J. Leukoc. Biol. 62, 20–29.
Chackerian, B., Long, E. M., Luciw, P. A., and Overbaugh, J. (1997) Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J. Virol. 71, 3932–3939.
Granelli-Piperno, A., Moser, B., Pope, M., Chen, D., Wei, Y., Isdell, F., et al. (1996) Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. J. Exp. Med. 184, 2433–2438.
Mori, K., Ringler, D. J., and Desrosiers, R. C. (1993) Restricted replication of simian immuno-deficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry. J. Virol. 67, 2807–2814.
Stephens, E. B., McClure, H. M., and Narayan, 0. (1995) The proteins of lymphocyte- and macrophage-tropic strains of simian immunodeficiency virus are processed differently in macro-phages. Virology 206, 535–544.
Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huanh, Y., Nagashima, K. A., et al. (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667–673.
Bieniasz, P. D., Friedell, R. A., Aramori, I., Ferguson, S. S. G., Caron, M. G., and Cullen, B. R. (1997) HIV-1—induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor. EMBO J. 16, 2599–2609.
Feng, Y., Broder, C. C., Kennedy, P. E., and Berger, E. A. (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872–877.
Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., et al. (1996) The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/Fusin and blocks HIV-1 entry. Nature 382, 829–833.
Oberlin, E., Amara, A., Bachelerie, F., Bessia, C., Virelizier, J.-L., Arenzana-Seisdedos, R., et al. (1996) The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell line-adapted HIV-1. Nature 382, 833–835.
Lapham, C. K., Ouyang, J., Chandrasekhar, B., Nguygen, N. Y., Dimitrov, D. S., et al. (1996) Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science 274, 602–605.
Brelot, A., Heveker, N., Pleskoff, 0., Sol, N., and Alizon, M. (1997) Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity. J. Virol. 71, 4744–4751.
Lu, Z.-H., Berson, J. F., Chen, Y.-H., Turner, J. D., Zhang, T.-Y., Sharron, M., et al. (1997) Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. Proc. Natl. Acad. Sci. USA 94, 6426–6431.
Pleskoff, 0., Sol, N., Labrosse, B., and Alizon, M. (1997) Human immunodeficiency virus strains differ in their ability to infect CD4+ cells expressing the rat homolog of CXCR-4 (fusin). J. Virol. 71, 3259–3262.
Tachibana, K., Nakajima, T., Sato, A., Igarashi, K., Shida, H., Iizssa, H., et al. (1997) CXCR4/fusin is not a species-specific barrier in murine cells for HIV-1 entry. J. Exp. Med. 185,1865–1870.
Chen, Z., Zhou, P., Ho, D. D., Landau, N. R., and Marx, P. A. (1997) Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 71, 2705–2714.
Willett, B. J., Picard, L., Hosie, M. J., Turner, J. D., Adema, K., et al. (1997) Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol. 71, 6407–6415.
Parolin, C., Borsetti, A., Choe, H., Farzan, M., Kolchinsky, P., Heesen, M., et al., (1998) Use of murine CXCR-4 as a second receptor by some T-cell-tropic human immunodeficiency viruses. J. Virol. 72, 1652–1656.
Picard, L., Wilkinson, D. A., McKnight, A., Gray, P. W., Hoxie, J. A., Clapham, P. R., and Weiss, R. A. (1997) Role of the amino-terminal extracellular domain of CXCR4 in human immunodeficiency virus type 1 entry. Virology 231, 105–111.
Davis, C. B., Dikic, I., Unutmaz, D., Hill, C. M., Arthos, J., Siani, M. A., et al. (1997) Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J. Exp. Med. 186, 1793–1798.
McKnight, A., Wilkinson, D., Simmons, G., Talbot, S., Picard, L., Ahuja, M., et al. (1997) Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J. Virol. 71, 1692–1696.
Endres, M. J., Clapham, P. R., Marsh, M., Ahuja, M., Davis Turner, J., McKnight, A., et al. (1996) CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87, 745–756.
Doranz, B. J., Grovit-Ferbas, K., Sharron, M., Mao, S.-H., Bidwell Goetz, M., Daar, E. S., et al. (1997) A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J. Exp. Med. 186, 1395–1400.
Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., and Lusso, P. (1995) Identification of RANTES, MIP-1 a and MIP-1β as the major HIV suppressive factors produced by CD8+ T cells. Science 270, 1811–1815.
Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., and Berger, E. A. (1996) CC CKR5: A RANTES, MIP-1 a, MIP-1 β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955–1958.
Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., et al. (1996) The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135–1148.
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., et al. (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661–666.
Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., et al. (1996) A dualtropic primary HIV -1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85,1149–1158.
Trkola, A., Dragic, T., Arthos, J., Binley, J. M., Olson, W. C., Allaway, G. P., et al. (1996) CD4-dependent, antibody-sensitive interactions between HIV-1 and its coreceptor CCR-5. Nature 384, 184–187.
Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., et al. (1996) CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384, 179–183.
Doranz, B. J., Lu, Z.-H., Rucker, J., Zhang, T.-Y., Sharron, M., Cen, Y.-H., et al. (1997) Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1. J. Virol. 71, 6305–6314.
Kuhmann, S. E., Platt, E. J., Kozak, S. L., and Kabat, D. (1997) Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses. J. Virol. 71, 8642–8656.
Atchison, R. E., Gosling, J., Monteclaro, F. S., Franci, C., Digilio, L., Charo, I. F., and Goldsmith, M. A. (1996) Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science 274, 1924–1926.
Picard, L., Simmons, G., Power, C. A., Meyer, A., Weiss, R. A., and Clapham, P. R. (1997) Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. J. Virol. 71, 5003–5011.
Rucker, J., Samson, M., Doranz, B. J., Libert, F., Berson, J. F., Yi, Y., et al. (1996) Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 87, 437–446.
Alkhatib, G., Ahuja, S. S., Light, D., Mummidi, S., Berger, E. A., and Ahuja, S. K. (1997) CC chemokine receptor 5-mediated signaling and HIV-1 co-receptor activity share common structural determinants. J. Biol. Chem. 272, 19,771–19,776.
Wu, L., LaRosa, G., Kassam, N., Gordon, C. J., Heath, H., Ruffing, N., et al. (1997) Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J. Exp. Med. 186, 1373–1381.
Ansari-Lari, M. A., Liu, X.-M., Metzker, M. L., Rut, A. R., and Gibbs, R. A. (1997) The extent of genetic variation in the CCR5 gene. Nature Genet. 16, 221–222.
Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., et al. (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273, 1856–1862.
Ross, T. M., Bieniasz, P. D., and Cullen, B. R. (1998) Multiple residues contribute to the inability of murine CCR-5 to function as a coreceptor for macrophage-tropic human immuno-deficiency virus type 1 isolates. J. Virol. 72, 1918–1924.
Dragic, T., Trkola, A., Lin, S. W., Nagashima, K. A., Kajumo, F., et al. (1997) Amino-terminal substitutions in the CCR5 co-receptor impair gp 120 binding and human immunodeficiency virus type-I entry. J. Virol. 72, 279–285.
Farzan, M., Choe, H., Vaca, L., Martin, K., Sun, Y., et al. (1997) A tyrosine-rich region in the N-terminus of CCR5 is important for HIV-1 entry and mediates an association between gp120 and CCR5. J. Virol. 72, 1160–1164.
Rizzuto, C. D., Wyatt, R., Hernandez-Ramos, N., Sun, Y., Kwong, P. D., Hendrickson, W. A., and Sodroski, J. (1998) A conserved HIV gp 120 glycoprotein structure involved in chemokine receptor binding. Science 280, 1949–1953.
Doms, R. W. and Peiper, S. C. (1997) Unwelcome guests with master keys: how HIV uses chemokine receptors for cellular entry. Virology 235, 179–190.
Marcon, L., Choe, H., Martin, K. A., Farzan, M., Ponath, P. D., Wu, L., et al. (1997) Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immuno-deficiency virus, SIVmac239. J. Virol. 71, 2522–2527.
Martin, K. A., Wyatt, R., Farzan, M., Choe, H., Marcon, L., Desjardins, E., et al. (1997) CD4-independent binding of SIV gp120 to rhesus CCR5. Science 278, 1470–1473.
Gosling, J., Monteclaro, F. S., Atchison, R. E., Arai, H., Tsou, C.-L., Goldsmith, M. S., et al. (1997) Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc. Natl. Acad. Sci. USA 94, 5061–5066.
Farzan, M., Choe, H., Martin, K. A., Sun, Y., Sidelko, M., Mackay, C. R., et al. (1997) HIV-1 entry and macrophage inflammatory protein-1 β-mediated signaling are independent functions of the chemokine receptor CCR5. J. Biol. Chem. 272, 6854–6857.
Weissman, D., Rabin, R. L., Arthos, J., Rubbert, A., Dybul, M., Swofford, R., et al. (1997) Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature 389, 981–985.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Aarons, E.J., Koup, R.A. (1999). Mutation Analysis of Receptors and Relationship of Receptor Usage to Disease. In: Hébert, C.A. (eds) Chemokines in Disease. Contemporary Immunology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-706-2_18
Download citation
DOI: https://doi.org/10.1007/978-1-59259-706-2_18
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-4762-1
Online ISBN: 978-1-59259-706-2
eBook Packages: Springer Book Archive